# Ganciclovir

NDC: 51817-171
Generic name: ganciclovir sodium
Labeler / Manufacturer: Pharmascience Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180424

FDA application: ANDA207645

## Active ingredients

- GANCICLOVIR SODIUM: 500 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51817-171"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51817-171
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3059c2da-d4a7-4aea-828c-20e671cb875c